Discrete Event Simulation to Evaluate Different Treatments of Diabetic Retinopathy Disease
- 1 Laboratory of Modeling and Optimization for Decisional, Industrial and Logistic Systems, College of Economic Sciences and Management, University of Sfax, Sfax, Tunisia
- 2 Higher Institute of Management, Gabes, Tunisia, Detached to Quassim University, College of Business and Economics, Saudi Arabia
- 3 Laboratory of Modeling and Optimization for Decisional, Industrial and Logistic Systems, College of Economic Sciences and Management, University of Sfax, Sfax, Tunisia
Abstract
Modeling approach using discrete event simulation has been proven to work well in modeling in health care. The aim of our paper is to propose a simula tion approach which shows realistic models presenting different possibl e treat ments in different stages of diabetic retinopathy. We have presented three models in order to choose the best treatment for diabetic retinopathy patients. The first model describes the flow of a patient through stages without any medical treatments. It takes 13 years to reach blindness. The second model which includes the laser photocoagulation treatments leads to blindness after 46 years. Then, the third model illustrates the involvement of vitrectomy operation and delays blindness by 23 years. To construct the models, data were taken from experienced doctors and professors of the ophthalmology department in the University hospital Habib Bourguiba and the endocrinology department in the University hospital Hedi Chaker in Sfax, Tunisia. Our objective is to delay reaching the blindness stage as late as possible. Three models were developed, verified and validated through many iterative implementations with ARENA simulation software.
- Makheswari, U. and Sudarsanam, D. (2012) A Review on Bio Informatics for Diabetic Mellitus. International Journal of Pharma Sciences and Research (IJPSR), 3, 389-395.
- Home, P. (2003) The Challenge of Poorly Controlled Diabetes Mellitus. Diabetes & Metabolism, 29, 101-109. https://doi.org/10.1016/S1262-3636(07)70015-0
- Harper, P.R., Sayyad, M.G., De Senna, V., Shahani, A.K., Yajnik, C.S. and Shelgikar, K.M. (2002) A Systems Modeling Approach for the Prevention and Treatment of Diabetic Retinopathy. European Journal of Operational Research, 150, 81-91. https://doi.org/10.1016/S0377-2217(02)00787-7
- Boutayeb, A. and Twizell, E.H. (2004) An Age Structured Model for Complications of Diabetes Mellitus in Morocco. Simulation Modelling Practice and Theory, 12, 77-87. https://doi.org/10.1016/j.simpat.2003.11.003
- Rauner, M. S., Kurt, H. and Eva, M. (2004) Using a Markov Model to Evaluate the Cost-Effectiveness of Diabetic Foot Prevention Strategies in Austria. Proceedings of the Western Multiconference, International Conference on Health Sciences Simulation, San Diego, 18-22 January 2004, 63-68.
- Piyush, R., Manich, R., Balaji, G., Rohini, G.V. and Manjiri, U.J. (2013) Prevalence of Diabetic Retinopathy in Western Indian Type 2 Diabetic Population: A Hospital-Based Cross-Sectional Study. Journal of Clinical and Diagnostic Research, 7, 1387-1390.
- Chatenoud, L., Thervet, E., Primo, J. and Bach, J.F. (1994) Anti-CD3 Antibody Induces Long-Term Remission of Overt Autoimmunity in Non Obese Diabetic Mice. Proceedings of the National Academy of Sciences, 91, 123-127. https://doi.org/10.1073/pnas.91.1.123
- Dwyer, M.S., Ballard, L.J., Palumbo, P.J., Trautmann, J.C. and Chu, C. (1985) Incidence of Diabetic Retinopathy and Blindness: A Population Based Study in Rochester. Minnesota. Diabetes Care, 8, 316-322. https://doi.org/10.2337/diacare.8.4.316
- Klein, R., Klein, B. and Moss S.E. (1984) Visual Impairment in Diabetes. Ophthalmology, 91, 1-9. https://doi.org/10.1016/S0161-6420(84)34337-8
- Abdelmouleh, S. (2004) Diabetic Retinopathy. Doctorate in Medicine Faculty’s Bookcase, University of Sfax.
- Sivaprasad, S. and Jackson, H. (2007) Blood Pressure Control in Type II Diabetics with Diabetic Retinopathy. Eye, 21, 708-711. https://doi.org/10.1038/sj.eye.6702307
- Dimond, B. (2004). National Institute for Clinical Excellence. International Journal of Technology Assessment in Health Care, 12, 84-84. https://doi.org/10.12968/bjom.2004.12.2.12025